-M Walker Researcher Activity Profile

Research Author Detailed Information 

M Walker Publication Rate By Year

M Walker has published 1 paper(s) in 1969, 1 paper(s) in 1991, 1 paper(s) in 2001, 1 paper(s) in 2006, 18 paper(s) in 2007, 2 paper(s) in 2008, for a total of 24 research publications in total.

M M Walker Author Information

LAST NAME: walker

FIRST NAME: m

INITIALS: M

AFFILIATION:

Papers

M Walker's Publication Record

1. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody. Year Published: 2001
The Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20007, USA.
2. Function of hormonally-induced corpora lutea in the domestic cat. Year Published: 2006
Department of Physiology and Pharmacology University of Queensland, St. Lucia Queensland, Australia 4067.
3. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis. Year Published: 2007
4. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Year Published: 2007
5. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333). Year Published: 2007
Stroke Trials Unit, University of Nottingham, Nottingham, UK.
6. Hyperglucagonaemia is not a primary metabolic defect in non-diabetic first-degree relatives from Type 2 diabetic families. Year Published: 2007
7. Prevalence and progression of diabetes in mitochondrial disease. Year Published: 2007
Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK, r.whittaker@ncl.ac.uk.
8. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis. Year Published: 2007
9. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Year Published: 2007
10. Independent component analysis of interictal fMRI in focal epilepsy: comparison with general linear model-based EEG-correlated fMRI. Year Published: 2007
Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College of London Queen Square, London WC1N 3BG, UK. r.rodionov@ion.ucl.ac.uk
11. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis. Year Published: 2007
Department of Surgery, University Hospital Birmingham NHS Trust, Birmingham, UK. m.walker.2@bham.ac.uk
12. Hyperglucagonaemia is not a primary metabolic defect in non-diabetic first-degree relatives from Type 2 diabetic families. Year Published: 2007
13. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Year Published: 2007
1Cardiovascular & Gastrointestinal Discovery Department, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK.
14. Selecting patients with young-onset colorectal cancer for mismatch repair gene analysis. Year Published: 2007
Department of Surgery, University Hospital Birmingham NHS Trust, Birmingham, UK. m.walker.2@bham.ac.uk
15. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Year Published: 2007
Cardiovascular & Gastrointestinal Discovery Department, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK. simon.poucher@astrazeneca.com
16. Prevalence and progression of diabetes in mitochondrial disease. Year Published: 2007
Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK. r.whittaker@ncl.ac.uk
17. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Year Published: 2007
18. Independent component analysis of interictal fMRI in focal epilepsy: comparison with general linear model-based EEG-correlated fMRI. Year Published: 2007
Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College of London Queen Square, London WC1N 3BG, UK. r.rodionov@ion.ucl.ac.uk
19. [The anesthesia nursing personnel in Switzerland--a report: establishing cooperation] Year Published: 1991
20. Prevalence and progression of diabetes in mitochondrial disease. Year Published: 2007
Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK. r.whittaker@ncl.ac.uk
21. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Year Published: 2007
Cardiovascular & Gastrointestinal Discovery Department, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, UK. simon.poucher@astrazeneca.com
22. Sister at sea. Year Published: 1969
23. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Year Published: 2008
Institute of Biomedical Sciences, Peninsula Medical School, Exeter, UK. rinkis@adhb.govt.nz
24. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Year Published: 2008
Institute of Biomedical Sciences, Peninsula Medical School, Exeter, UK, and Auckland Diabetes Centre, Greenlane Clinical Centre, Auckland, New Zealand.